Key result
Prostacyclin and thromboxane interactions drive opposing effects on vascular tone and platelet aggregation.
Authors
Loading...
May inform selective antithrombotic strategies; leaves open prospective clinical validation before practice change.
Key points are not available for this paper at this time.
WHITFLE et al. (1983) studied this question. Pharmacological interactions between prostacyclin and thromboxanes mediate critical opposing effects on vascular tone and platelet aggregation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: